Regulating medical devices in the ‘Internet of things’
New research led by University of Melbourne is exploring the gap between regulation and practice in diabetes devices that are part of the Internet of Things.
Joining the dots on diabetes and COVID-19
People living with diabetes during the COVID-19 pandemic need some extra steps to protect their health, advise experts including the University of Melbourne.
Q&A: A new way to treat type 2 diabetes?
The discovery of how a key protein works to reduce blood glucose levels could lead to a more effective type 2 diabetes drug, say University of Melbourne experts
Staying active in lockdown can make for a better normal
Melburnians need to stay responsibly active given lockdowns are recipes for non-communicable diseases like heart disease warns University of Melbourne expert
Sea snail venom holds clues for diabetes treatment
A new study, that the University of Melbourne is part of, finds modified human insulin that mimics fast-acting sea snail venom is a potential diabetes treatment
Science, society and drug design
After being the first in his family to go to university, biochemist Sir Thomas Blundell has worked in music, local council, medical research and advisor to a PM
Different fat cell types may be key to obesity
University of Melbourne-led research discovers fat cells aren't all the same – some release fat, some help to burn fat, and the balance may influence obesity.
Bringing 3D imaging to kidney patients
3D computer imaging of kidney disease can readily bring highly detailed imaging into clinical settings, finds University of Melbourne and Austin Health research
The vaccine that may help prevent type 1 diabetes
New University of Melbourne research finds that the rotavirus vaccine saving young lives around the world may also help prevent type 1 diabetes.
Personalising blood sugar targets
University of Melbourne researchers have developed a tool to help GPs set personalised blood sugar targets and medication plans for type 2 diabetes patients.